HIMS to Introduce Compounded GLP-1 Injections, What Plan Sponsors Need to Know Scripta May 28, 2024 3 min read Updated: Jun 14, 2024 Hims & Hers' (HIMS) latest move to introduce compounded GLP-1 injections into its weight loss program is stirring up excitement and raising a few eyebrows among plan sponsors
The decision is based on the time elapsed since your missed dose and follows the FDA-approved dosing guidelines
Cancer 118:21382147 Sengupta S, Sobo M, Lee K, Senthil Kumar S, White AR, Mender I, Fuller C, Chow LM, Fouladi M, Shay JW (2018) Induced telomere damage to treat telomerase expressing therapy-resistant pediatric brain tumors
Your provider will ensure you know the correct technique and how to rotate sites effectively